Evidence quality 4.75/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 5/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
● your factors — click this risk ▾ to reveal
- Your factors
≈ As likely as
Perceived
Lyme disease occupies a peculiar niche in risk perception: in the northeastern United States, it is a near-universal worry during tick season, with parents, hikers, and gardeners treating every embedded tick as a medical emergency. In non-endemic regions — the Mountain West, most of the South, the Pacific Northwest — the same tick bite barely registers. No rigorous national poll isolates "fear of Lyme disease from a single tick bite" as a standalone question, so the perceived estimate here is editorial intuition calibrated by regional conversation patterns rather than survey data.
Rough estimate: endemic-area residents often guess 30–50% per bite; non-endemic residents guess ~0%
Source: editorial intuition, not polled
Actual
~1.2–3.4% transmission rate per Ixodes scapularis bite (attachment <72 hrs, endemic area)
persons bitten by Ixodes scapularis (deer tick) in an endemic area of the northeastern/upper-midwestern US
Show derivation
CDC estimates ~476,000 new US Lyme infections per year (2024 revised estimate, up from the earlier 30,000 confirmed-case figure). US population ~335 million, but roughly 95% of cases concentrate in 15 northeastern and upper-midwestern states with a combined population of ~115 million. Annual per-capita hazard in the endemic footprint ≈ 476,000 × 0.95 / 115,000,000 ≈ 3.93 × 10⁻³. Compounded over 59 adult years: 1 - (1 - 0.00393)^59 ≈ 0.207. Adjusting upward slightly for outdoor-active adults (gardeners, hikers, dog walkers) who accumulate more tick encounters than sedentary residents gives a central estimate of ~0.25, or about 1 in 4 lifetime for a moderately active adult in an endemic state. The uncertainty band spans the sedentary endemic resident (~0.15) to the avid outdoors person in peak-incidence counties (~0.40).
Caveats: The normalized lifetime figure applies specifically to moderately active adults …
The normalized lifetime figure applies specifically to moderately active adults living in the 15-state endemic corridor (Connecticut to Minnesota). Outside that footprint, lifetime Lyme risk drops by roughly two orders of magnitude. The per-bite transmission rate depends critically on attachment duration: near-zero under 36 hours, rising steeply after 72 hours. Nymphal ticks (May–July) cause the majority of human infections because they are small enough to go unnoticed; adult ticks, being larger, are found and removed sooner. The 476,000/year CDC estimate includes clinically diagnosed cases that may not have confirmatory serology, so it is substantially higher than the ~30,000 confirmed cases reported through passive surveillance. Post-bite prophylactic doxycycline (single 200 mg dose within 72 hours) reduces transmission by ~87% per Nadelman et al. and is recommended by IDSA guidelines in endemic areas. No human Lyme vaccine is approved as of mid-2026: LYMErix was withdrawn in 2002, and the Pfizer/Valneva candidate VLA15 (now LB6V) reported roughly 74% efficacy in its Phase 3 VALOR trial in March 2026, with regulatory filings to the FDA and EMA planned for late 2026. This entry does not constitute medical advice.
How the risk varies
The headline figure averages across very different situations. Here’s how the probability varies by scenario or context:
1 in 31 · 3.2%
Nadelman et al. 2001 placebo arm: 3.2% per bite. Most recognized bites involve shorter attachment.
1 in 5.0 · 20%
Shapiro 2014: erythema migrans risk was 25% in the placebo arm when the tick had fed ≥72 hrs (vs 0% if <72 hrs); 0.20 is a conservative estimate for prolonged attachment.
1 in 4.0 · 25%
CDC 476K cases/yr across ~115M endemic-region population, compounded over 59 years with outdoor-activity adjustment.
1 in 200
Remaining ~5% of US Lyme cases spread across ~220M people in non-endemic states; lifetime risk rounds to ~1 in 200.
Bar length and shade rank these scenarios against each other, not against other risks. The exact odds are shown beside each.
Related risks
Other risks on similar themes — for exploring related fears.
Tick illness (forest)
What are the odds of catching a tick-borne illness from walking in the forest?
Unprotected sex
What are the odds of catching an STI from a single unprotected sexual encounter with a new partner?
Adventure sports
What are the odds of a serious injury from regular participation in surfing, mountain biking, or rock climbing?
Drug-resistant infection
What is the risk of developing a serious antibiotic-resistant infection?
Pick challenger
Lyme disease is the most common vector-borne illness in the United States, with the CDC estimating roughly 476,000 new infections per year — a figure that dwarfs the ~30,000 confirmed cases reported through traditional surveillance. The per-bite transmission rate from an infected Ixodes scapularis (deer tick) runs about 1–3% when the tick is found and removed within 72 hours, but climbs to 20–25% if the tick feeds to engorgement. The critical variable is attachment duration: transmission is effectively zero under 36 hours, because the Borrelia burgdorferi spirochete needs time to migrate from the tick’s midgut to its salivary glands. For a moderately active adult living in the 15-state endemic corridor stretching from Virginia to Maine and west to Minnesota, the compounded lifetime probability of contracting Lyme at least once is roughly 1 in 4.
The perception gap runs in opposite directions depending on geography. In endemic counties (Dutchess County, New York; Windham County, Connecticut; much of Wisconsin), residents tend to calibrate their worry reasonably well, sometimes slightly high per individual bite but roughly right over a lifetime of outdoor exposure. In non-endemic states, tick-borne disease barely registers as a concern, which is also roughly correct: only about 5% of US Lyme cases originate outside the 15-state core. The entry is tagged calibrated rather than overrated or underrated because the national average hides two populations whose intuitions point in opposite directions and both are, within an order of magnitude, justified.
The number is highly modifiable. Prompt daily tick checks after outdoor activity reduce per-bite risk to near-zero by keeping attachment under 36 hours. A single 200 mg dose of doxycycline within 72 hours of a recognized bite reduced erythema migrans incidence by 87% in the Nadelman et al. trial. Conversely, outdoor workers in forestry, landscaping, and agriculture in endemic states face roughly triple the baseline encounter rate. The lifetime figure of 1 in 4 is a population average for endemic-region adults with moderate outdoor habits; it is not a personal forecast, and individual behavior shifts it substantially in either direction.
Related tidbits
A single deer-tick bite in an endemic area carries roughly a 1.2 to 3.4% transmission risk, far below the 30 to 50% endemic-area residents often guess. Over a lifetime of moderate outdoor exposure, cumulative odds reach about ~1 in 4 lifetime (US adult in endemic region).
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] US Centers for Disease Control and Prevention (CDC) — Lyme Disease: Data and Statistics
Lyme Disease: Data and StatisticsSee all 2 Likelier entries citing this source →
- Statistic
CDC estimates approximately 476,000 people are diagnosed and treated for Lyme disease each year in the United States.- Excerpt
“"CDC estimates that approximately 476,000 people may get Lyme disease each year in the United States. This estimate was derived using methods including insurance claims data, clinical laboratory data, and self-reported physician-diagnosed cases." ”
- Source data from
- 2024-03-11
- Accessed
- 2026-04-18 · archived copy
- Calculation
- The 476,000/year estimate is the population-level anchor. Divided across the endemic-region population of ~115 million (the 15 states that account for ~95% of confirmed cases), the annual per-capita hazard is ~3.93 × 10⁻³. Compounded over 59 adult years: 1 - (1 - 0.00393)^59 ≈ 0.207. With a modest upward adjustment for moderate outdoor activity, the central lifetime estimate is ~0.25.
-
[2] New England Journal of Medicine — Prophylaxis with Single-Dose Doxycycline for the Prevention of Lyme Disease after an Ixodes scapularis Tick Bite
Prophylaxis with Single-Dose Doxycycline for the Prevention of Lyme Disease after an Ixodes scapularis Tick Bite- Statistic
3.2% of placebo recipients developed erythema migrans after an Ixodes scapularis bite in a Lyme-endemic area; 0.4% of doxycycline recipients developed it.- Excerpt
“"Erythema migrans developed at the site of the tick bite in a significantly smaller proportion of the subjects in the doxycycline group than of those in the placebo group (1 of 235 subjects [0.4 percent] vs. 8 of 247 subjects [3.2 percent], P<0.04)." ”
- Source data from
- 2001-07-12
- Accessed
- 2026-04-18 · archived copy
- Calculation
- Nadelman et al. 2001 provides the per-bite baseline: 3.2% of placebo recipients (no prophylaxis) developed erythema migrans in an endemic area. This is the per-bite transmission rate used as the native figure. The doxycycline arm (0.4%) informs the prophylactic-doxycycline personal factor multiplier (~0.13×). Subjects had to present within 72 hours of tick removal, so this rate reflects bites with attachment duration up to ~72 hours, biased toward shorter attachments since people who find ticks quickly are over-represented.
- Independence
- RCT conducted in Westchester County, NY — independent clinical trial data, not derived from CDC surveillance.
-
[3] New England Journal of Medicine — Lyme Disease
Lyme Disease- Statistic
Even in highly endemic areas, the risk of Lyme disease transmission from a recognized tick bite is low (1 to 3%); in one study the risk of erythema migrans was 25% if the tick had fed for 72 or more hours and 0% if it had fed for less than 72 hours.- Excerpt
“"Consequently, even in areas where Lyme disease is highly endemic, the risk of disease transmission from a recognized bite is low (1 to 3%). [...] In a study comparing doxycycline with placebo in participants who had been bitten by nymphal ticks for which the duration of feeding could be assessed, the risk of erythema migrans in the placebo group was 25% (3 of 12 bites) if the tick had fed for 72 or more hours and 0% (0 of 48 bites) if the tick had fed for less than 72 hours." ”
- Source data from
- 2014-05-01
- Accessed
- 2026-04-18 · archived copy
- Calculation
- Shapiro 2014 NEJM review states the overall risk of transmission from a recognized bite in endemic areas is low (1–3%), and reports a sharp attachment-duration threshold: in the cited placebo arm, the risk of erythema migrans was 25% if the tick had fed for 72 or more hours and 0% if it had fed for less than 72 hours. The review elsewhere notes that transmission from infected nymphal ticks generally occurs only after 36–48 hours of attachment. This underpins the regional_breakdown rows stratified by attachment duration and the personal_factor_multiplier for prompt tick removal vs prolonged attachment.
- Independence
- Narrative review synthesizing multiple clinical studies — independent secondary analysis, not derived from CDC surveillance data.